RJA
STAA icon

Raymond James & Associates’s STAAR Surgical STAA Stock Holding History

Raymond James & Associates’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,243
Closed -$452K – 3945
2023
Q3 		$452K Sell
11,243
-1,453
-11% -$68K ﹤0.01% 2962
2023
Q2 		$667K Sell
12,696
-4,403
-26% -$268K ﹤0.01% 2742
2023
Q1 		$1.09M Sell
17,099
-2,219
-11% -$145K ﹤0.01% 2403
2022
Q4 		$938K Buy
19,318
+3,945
+26% +$247K ﹤0.01% 2465
2022
Q3 		$1.08M Buy
15,373
+605
+4% +$51.8K ﹤0.01% 2342
2022
Q2 		$1.05M Buy
14,768
+2,064
+16% +$133K ﹤0.01% 2408
2022
Q1 		$1.01M Buy
12,704
+6,234
+96% +$464K ﹤0.01% 2585
2021
Q4 		$591K Sell
6,470
-3,947
-38% -$423K ﹤0.01% 2965
2021
Q3 		$1.34M Sell
10,417
-652
-6% -$91.2K ﹤0.01% 2387
2021
Q2 		$1.69M Buy
11,069
+4,892
+79% +$644K ﹤0.01% 2220
2021
Q1 		$651K Sell
6,177
-2,106
-25% -$211K ﹤0.01% 2813
2020
Q4 		$656K Buy
8,283
+1,127
+16% +$82.5K ﹤0.01% 2628
2020
Q3 		$405K Buy
+7,156
New +$385K ﹤0.01% 2773

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Raymond James & Associates's STAA Position: Q4 2023 in Review

Raymond James & Associates sold out of STAAR Surgical (STAA) in Q4 2023, closing a stake of 11,243 shares — an estimated $452K sold.

Raymond James & Associates first reported a position in STAA in Q3 2020 and held it in 13 quarters. The position peaked at $1.69M in Q2 2021. 207 funds tracked by Wall St. Rank hold STAA as of Q4 2023.

  • Raymond James & Associates reported no remaining STAAR Surgical position as of Q4 2023 after selling out during the quarter.
  • Raymond James & Associates sold 11,243 STAAR Surgical shares in Q4 2023, an estimated $452K.
  • Raymond James & Associates first reported a position in STAAR Surgical in Q3 2020 and held it in 13 quarters.
  • Raymond James & Associates's STAAR Surgical position peaked at $1.69M in Q2 2021.
  • 207 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.